Search Results - "Diwan, Tayyab S."

Refine Results
  1. 1

    Use of Elderly Allografts in Liver Transplantation by Paterno, Flavio, Wima, Koffi, Hoehn, Richard S, Cuffy, Madison C, Diwan, Tayyab S, Woodle, Steve E, Abbott, Daniel E, Shah, Shimul A

    Published in Transplantation (01-01-2016)
    “…INTRODUCTIONThe use of liver allografts from elderly donors (≥70 years) has increased because of organ shortage and increased life expectancy. The aim of this…”
    Get full text
    Journal Article
  2. 2

    Hospital utilization and consequences of readmissions after liver transplantation by Paterno, Flavio, MD, Wilson, Gregory C., MD, Wima, Koffi, MS, Quillin, Ralph C., MD, Abbott, Daniel E., MD, Cuffy, Madison C., MD, MBA, Diwan, Tayyab S., MD, Kaiser, Tiffany, PharmD, Woodle, E. Steve, MD, Shah, Shimul A., MD, MHCM

    Published in Surgery (01-10-2014)
    “…Background Preventable readmissions have become a focal point for controlling cost and improving quality in medicine. The frequency and causes of readmissions…”
    Get full text
    Journal Article
  3. 3

    The impact of morbid obesity on resource utilization after renal transplantation by Kim, Young, MD, Chang, Alex L., MD, Wima, Koffi, MS, Ertel, Audrey E., MD, MS, Diwan, Tayyab S., MD, FACS, Abbott, Daniel E., MD, FACS, Shah, Shimul A., MD, MHCM, FACS

    Published in Surgery (01-12-2016)
    “…Background A growing number of renal transplant recipients have a body mass index ≥40. While previous studies have shown that patient and graft survival are…”
    Get full text
    Journal Article
  4. 4

    The Impact of Proteasome Inhibition on Alloantibody-Producing Plasma Cells In Vivo by DIWAN, Tayyab S, RAGHAVAIAH, Suresh, BURNS, Justin M, KREMERS, Walter K, GLOOR, James M, STEGALL, Mark D

    Published in Transplantation (15-03-2011)
    “…Donor specific alloantibody producing plasma cells (DSA-PCs) appear resistant to conventional immunosuppressive agents. This study aimed to determine the…”
    Get full text
    Journal Article
  5. 5

    Addressing the challenges of sleeve gastrectomy in end-stage renal disease: Analysis of 100 consecutive renal failure patients by Kim, Young, MD, Shi, Junzi, MD, Freeman, Christopher M., MD, Jung, Andrew D., MD, Dhar, Vikrom K., MD, Shah, Shimul A., MD, Woodle, E. Steve, MD, Diwan, Tayyab S., MD

    Published in Surgery (01-08-2017)
    “…Background While previous studies have demonstrated short-term efficacy of laparoscopic sleeve gastrectomy in candidates awaiting renal transplantation, the…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    The Center Volume-Outcome Effect in Pancreas Transplantation: A National Analysis by Kim, Young, MD, Dhar, Vikrom K., MD, Wima, Koffi, MS, Jung, Andrew D., MD, Xia, Brent T., MD, Hoehn, Richard S., MD, Diwan, Tayyab S., MD, Shah, Shimul A., MD, MHCM, FACS

    Published in The Journal of surgical research (01-06-2017)
    “…Abstract Background While increased hospital volume has been correlated with improved outcomes in certain surgical procedures, the effect of center volume on…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Liver Transplantation and Bariatric Surgery: Timing and Outcomes by Diwan, Tayyab S., Rice, Teresa C., Heimbach, Julie K., Schauer, Daniel P.

    Published in Liver transplantation (01-09-2018)
    “…Nonalcoholic steatohepatitis (NASH) is projected to become the leading indication for liver transplantation (LT) in the next decade in the United States…”
    Get full text
    Journal Article
  12. 12

    Obesity management for the hepatologist-What to do, how to do it and why? by Watt, Kymberly D, Paul, Sonali, Khan, Mohammad Qasim, Siddiqui, Mohammad, Lam, Jenny, Diwan, Tayyab S, Camilleri, Michael

    Published in Hepatology (Baltimore, Md.) (19-09-2023)
    “…Obesity is highly prevalent in hepatology clinics and has a significant impact on chronic liver disease and patient management. Hepatologists and…”
    Get full text
    Journal Article
  13. 13

    Long‐term outcomes in patients with obesity and renal disease after sleeve gastrectomy by Kassam, Al‐Faraaz, Mirza, Ahmad, Kim, Young, Hanseman, Dennis, Woodle, E. Steve, Quillin, Ralph C., Johnson, Bobby L., Govil, Amit, Cardi, Michael, Schauer, Daniel P., Smith, Eric P., Diwan, Tayyab S.

    Published in American journal of transplantation (01-02-2020)
    “…Morbid obesity is a barrier to kidney transplant in patients with end‐stage renal disease (ESRD). Laparoscopic sleeve gastrectomy (SG) is an increasingly…”
    Get full text
    Journal Article
  14. 14

    Bariatric surgery and left ventricular assist device in patients with heart failure: A systematic review and meta-analysis by Sharma, Ishna, Nakanishi, Hayato, Hage, Karl, Marrero, Katie, Diwan, Tayyab S., daSilva-deAbreu, Adrian, Davis Jr, Scott S., Clapp, Benjamin, Ghanem, Omar M.

    Published in The American journal of surgery (01-09-2023)
    “…The role of metabolic and bariatric surgery (MBS), in synergy with left ventricular assist device (LVAD) implantation, in the scope of end-stage heart failure…”
    Get full text
    Journal Article
  15. 15

    Obesity, transplantation, and bariatric surgery: An evolving solution for a growing epidemic by Diwan, Tayyab S., Lee, Tiffany C., Nagai, Shunji, Benedetti, Enrico, Posselt, Andrew, Bumgardner, Ginny, Noria, Sabrena, Whitson, Bryan A., Ratner, Lloyd, Mason, David, Friedman, Jon, Woodside, Kenneth J., Heimbach, Julie

    Published in American journal of transplantation (01-08-2020)
    “…The increasing obesity epidemic has major implications in the realm of transplantation. Patients with obesity face barriers in access to transplant and unique…”
    Get full text
    Journal Article
  16. 16

    Bariatric surgery and the diseased kidney: a 5-year assessment of safety and postoperative renal outcomes by Abi Mosleh, Kamal, Sample, Jack W., Belluzzi, Amanda, Bartosiak, Katarzyna, Buttar, Davekaran, Betancourt, Richard S., Kukla, Aleksandra, Diwan, Tayyab S., Ghanem, Omar M.

    Published in Surgical endoscopy (01-07-2024)
    “…Background Obesity and its related medical conditions are well-established contributors to the development of chronic kidney disease (CKD). Metabolic and…”
    Get full text
    Journal Article
  17. 17

    Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients by Luckett, Keith, Kaiser, Tiffany E., Bari, Khurram, Safdar, Kamran, Schoech, Michael R., Apewokin, Senu, Diwan, Tayyab S., Cuffy, Madison C., Anwar, Nadeem, Shah, Shimul A.

    “…Given the shortage of available liver grafts, transplantation (LTx) of hepatitis C virus antibody-positive, nucleic acid test-negative (HCV Ab+/NAT-) livers…”
    Get full text
    Journal Article
  18. 18

    Impact of obesity on dialysis and transplant and its management by Diwan, Tayyab S., Cuffy, Madison C., Linares‐Cervantes, Ivan, Govil, Amit

    Published in Seminars in dialysis (01-05-2020)
    “…Obesity is increasing to unprecedented levels, including in the end‐stage kidney disease population, where upwards of 60% of kidney transplant patients are…”
    Get full text
    Journal Article
  19. 19

    Psychosocial considerations in the combined bariatric surgery and organ transplantation population: a review of the overlapping pathologies and outcomes by Fipps, David C., Sinha, Shirshendu, Diwan, Tayyab S., Clark, Matthew M.

    Published in Current opinion in organ transplantation (01-12-2022)
    “…This review highlights the salient data of the psychosocial concerns that influence outcomes of bariatric surgery and organ transplantation. Bariatric surgery…”
    Get full text
    Journal Article
  20. 20

    Management of Patients With Kidney Disease Undergoing Bariatric Surgery: A Multidisciplinary Approach by Kukla, Aleksandra, Kudva, Yogish C, Navratil, Pavel, Sahi, Sukhdeep S, Benzo, Roberto P, Fipps, David C, Erickson, Avery E, Majorowicz, Rachael R, Clark, Matthew M, Schinstock, Carrie A, Shah, Pankaj, Shah, Meera, Diwan, Tayyab S

    Published in Mayo Clinic proceedings (01-03-2024)
    “…Bariatric surgery is increasingly recognized as a safe and effective treatment for obesity in patients with chronic kidney disease (CKD), including stages 4,…”
    Get full text
    Journal Article